Last edition
News about Biotechnology
The US Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has formally granted Orphan Drug Designation (ODD) to Innovent Biologics's fully-human B-Cell Maturation Antigen (BCMA)-targetted Chimeric Antigen Receptor (CAR) T-cell therapy
Biotechnology | 17/02/2022 | By Darshana | 859
Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry
Biotechnology | 18/10/2021 | By Darshana | 787
An integrated clinical decision support system (CDSS) using artificial intelligence (AI) could be useful to health workers in primary and secondary healthcare settings to overcome the present challenges including a lack of adequate manpower in the system, according to a study sponsored by NITI Aayog and UK-Department of International Trade
Biotechnology | 01/09/2021 | By Darshana | 485
Nucleome unveils South Asia's largest genomics research centre in Hyderabad
In a move that will mark the beginning of a new era in India's genomics capability, Nucleome Informatics has unveiled South Asia's largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad
Biotechnology | 27/08/2021 | By Darshana | 490
MaxCyte, Inc., a leading provider of cell-engineering platform technologies, announced the signing of a clinical and commercial license with Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines.
Biotechnology | 10/08/2021 | By Darshana | 480
Pharmexcil seeks list of products requiring SION norms fixation from exporters
The Pharmaceutical Export Promotion Council of India (Pharmexcil) has asked exporters to provide a list of products requiring Standard Input Output Norms (SION) fixation to help them fulfill export obligations in a timely manner
Biotechnology | 02/08/2021 | By Darshana | 480
Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint clinical development and commercialization of HQP1351(olverembatinib), a third-generation BCR-ABL inhibitor and a core drug candidate of Ascentage Pharma
Biotechnology | 16/07/2021 | By Darshana | 709
Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC
Abbott, the global healthcare company, has received approval from the Subject Expert Committee (SEC) at Central Drugs Standard Control Organisation (CDSCO) for importing and marketing of the fixed dose combination of dydrogesterone+estradiol (2.5 mg + 0.5mg) tablets
Biotechnology | 15/07/2021 | By Darshana | 757
Lupin gets US FDA nod to market generic Kerydin topical solution
Global pharma major Lupin Limited announced the US launch of tavaborole topical solution, 5% having received an approval from the United States Food and Drug Administration (FDA)
Biotechnology | 13/07/2021 | By Darshana | 510
IGBA launches a whitepaper: A vision for the generic and biosimilar medicines industry
The International Generic and Biosimilar Medicines Association (IGBA) has announced the launch of a whitepaper: A vision for the generic and biosimilar medicines industry, which covers the strong contribution of this pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry
Biotechnology | 08/07/2021 | By Darshana | 301
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy